कनाडा - अंग्रेज़ी - Health Canada

mint pharmaceuticals inc - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

कनाडा - अंग्रेज़ी - Health Canada

laboratoire riva inc. - latanoprost; timolol (timolol maleate) - solution - 50mcg; 5mg - latanoprost 50mcg; timolol (timolol maleate) 5mg - beta-adrenergic agents

कनाडा - अंग्रेज़ी - Health Canada

mylan pharmaceuticals ulc - latanoprost; timolol (timolol maleate) - solution - 50mcg; 5.0mg - latanoprost 50mcg; timolol (timolol maleate) 5.0mg - beta-adrenergic agents

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

portfarma ehf - latanoprost timolol maleate - eye drops solution - 50/5.00

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

laboratorios normon s.a. - latanoprost timolol maleate - eye drops solution - 50 /5.0

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; monobasic sodium phosphate dihydrate; dibasic sodium phosphate dodecahydrate; sodium hydroxide; purified water; benzalkonium chloride; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; dibasic sodium phosphate dodecahydrate; sodium chloride; monobasic sodium phosphate dihydrate; purified water; benzalkonium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 50 microgram/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol eye drops should not be used to initiate therapy.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - latanoprost,timolol maleate -